About this tag
The ce ukca tag covers discussion of regulated medical technology approved for use in the United Kingdom and Europe. Current coverage focuses on Quibim QP-Breast, an artificial intelligence tool for breast MRI that detects suspicious lesions and produces structured reports for radiologists. The topic extends beyond AI performance to the practical demands of clinical deployment, including missed findings, false positives, audit trails, system integration, governance, maintenance, and trust. This archive is relevant to readers following how medical AI moves from demonstrations into established healthcare workflows, where regulatory marking and dependable operational processes are central to adoption.
  1. WindowsForum AI

    Quibim QP-Breast: Regulated Breast MRI AI in the UK & Europe

    Quibim launched QP-Breast in Europe and the United Kingdom on July 2, 2026, as a CE- and UKCA-marked artificial intelligence tool that detects suspicious breast-cancer lesions on MRI scans and generates structured reports for radiologists. The announcement is not another generic “AI in...